Literature DB >> 24861772

Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese.

Tielong Tang1, Hui Xue, Shu Cui, Zhiyong Gong, Zhonghai Fei, Shulin Cheng, Chunyan Gui.   

Abstract

To assess whether polymorphisms of the interleukin-23 receptor (IL23R) gene are associated with bladder transitional cell carcinoma because chronic inflammation contributes to bladder cancer and the IL23R is known to be critically involved in the carcinogenesis of various malignant tumors. 226 patients with bladder cancer and 270 age-matched controls were involved in the study. Polymerase chain reaction-restriction fragment length polymorphism was used for genotyping. Genotype distribution and allelic frequencies between patients and controls were compared. In all three single nucleotide polymorphisms of IL23R studied, the distribution of genotype and allele frequencies of rs10889677 differed significantly between patients and controls. The frequency of allele C of rs10889677 was significantly increased in cases compared with controls (0.2898 vs. 0.1833, odds ratio 1.818, 95 % confidence interval 1.349-2.449). The result indicates that IL23R may play an important role in the susceptibility of bladder cancer in Chinese population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24861772     DOI: 10.1007/s10689-014-9731-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

1.  Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.

Authors:  Dan Leibovici; H Barton Grossman; Colin P Dinney; Randal E Millikan; Seth Lerner; Yunfei Wang; Jian Gu; Qiong Dong; Xifeng Wu
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study.

Authors:  Bin Chen; Zhirong Zeng; Lixia Xu; Xiaoqin Wu; Jun Yu; Ling Xue; Yuantao Hao; Yiming Wang; Joseph J Y Sung; Minhu Chen; Pinjin Hu
Journal:  Cancer Epidemiol       Date:  2010-09-21       Impact factor: 2.984

6.  Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility.

Authors:  Ming-Hsien Chien; Chung-Han Hsin; Lin Shih-Shen Chou; Tsung-Te Chung; Chien-Huang Lin; Meng-Shih Weng; Ming-Yung Chou; Mu-Kuan Chen; Shun-Fa Yang
Journal:  Head Neck       Date:  2011-06-29       Impact factor: 3.147

7.  Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity.

Authors:  Amanda K Huber; Eric M Jacobson; Krystian Jazdzewski; Erlinda S Concepcion; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

8.  Chronic inflammation and breast cancer recurrence.

Authors:  Steven W Cole
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 9.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  A miRNA binding site single-nucleotide polymorphism in the 3'-UTR region of the IL23R gene is associated with breast cancer.

Authors:  Lihong Wang; Wei Liu; Wei Jiang; Jing Lin; Yongdong Jiang; Bo Li; Da Pang
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

View more
  2 in total

Review 1.  Association of IL-23R Polymorphisms (rs6682925, rs10889677, rs1884444) With Cancer Risk: A PRISMA-Compliant Meta-Analysis.

Authors:  Xing-Han Liu; Zhi-Ming Dai; Hua-Feng Kang; Shuai Lin; Xiao-Bin Ma; Meng Wang; Kang Liu; Cong Dai; Xi-Jing Wang; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

2.  Associations of Functional MicroRNA Binding Site Polymorphisms in IL23/Th17 Inflammatory Pathway Genes with Gastric Cancer Risk.

Authors:  Kaiyan Dong; Yajuan Xu; Qian Yang; Jiachen Shi; Jicheng Jiang; Yi Chen; Chunhua Song; Kaijuan Wang
Journal:  Mediators Inflamm       Date:  2017-10-08       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.